BiotechTube
Home/TopAlliance Biosciences/Kevin Li, Ph.D.
KL

Kevin Li, Ph.D.

Vice President of Regulatory Affairs

TopAlliance Biosciences

Therapeutic Areas

Oncology

TopAlliance Biosciences Pipeline

DrugIndicationPhase
LOQTORZI (Toripalimab)Nasopharyngeal Carcinoma (and other undisclosed oncology indications)Approved
Undisclosed ADC ProgramsOncologyNot Disclosed

Leadership Team at TopAlliance Biosciences

NL
Ning Li, M.D., Ph.D.
Chairman of the Board
SY
Sheng Yao, Ph.D.
Chief Executive Officer and Executive Director
PK
Patricia Keegan, M.D.
Chief Medical Officer
MH
Monica Hughes
Vice President of Project and Portfolio Management
View full TopAlliance Biosciences profile